Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,406
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
for
Ovarian Cancer
Location: St Louis MO, Peoria IL, Nashville TN, Houston TX,
Sponsor: Nerviano Medical Sciences
Sex: Female
Age: 18+
Code: NCT06930755
Phase 1, Recruiting
WashU DIEP Flap Video and Patient Understanding Improvement
for
Breast Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18+
Code: NCT06864754
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St Louis MO, Chicago IL, Cincinnati OH, Fort Wayne IN,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: St Louis MO, Nashville TN, Ann Arbor MI,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07020221
Phase 1, Phase 2, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: St Louis MO, Kansas City KS, Chicago IL, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
for
Metastatic Pancreatic Ductal Adenocarcinoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06904378
Phase 1, Phase 2, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: St Louis MO, Memphis TN, Nashville TN, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: St Louis MO, Carterville IL, Springfield IL,
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
for
Large B-cell Lymphoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07052305
Phase 1, Recruiting
ColoCare Study - Colorectal Cancer Cohort
for
Colorectal Cancer
Location: St Louis MO, Knoxville TN, Tampa FL, Salt Lake City UT,
Sponsor: University of Utah
Sex: All
Age: 18 - 70+
Code: NCT02328677
Recruiting
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Location: St Louis MO, Indianapolis IN, Chicago IL, Ann Arbor MI,
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 65 - 70+
Code: NCT05612347
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase 3, Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: St Louis MO, Nashville TN, Chicago IL, Columbus OH,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase 1, Phase 2, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: St Louis MO, Kansas City KS, Cincinnati OH, Columbus OH,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: St Louis MO, Indianapolis IN, Kansas City MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase 2, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: St Louis MO, Nashville TN, Madison WI, Saint Paul MN,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase 1, Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: St Louis MO, Chicago IL, Madison WI, Milwaukee WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase 1, Phase 2, Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors